Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study
维奈托克联合奥妥珠单抗治疗既往未接受治疗的慢性淋巴细胞白血病：随机3期CLL14研究的6年结果
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024024631
Al-Sawaf, Othman; Robrecht, Sandra; Zhang, Can; Olivieri, Stefano; Chang, Yi Meng; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl-Anton; Sivchev, Liliya; Niemann, Carsten Utoft; Schwarer, Anthony; Loscertales, Javier; Weinkove, Robert; Strumberg, Dirk; Kilfoyle, Allanah; Manzoor, Beenish S; Jawaid, Dureshahwar; Emechebe, Nnadozie; Devine, Jacob; Boyer, Michelle; Runkel, Eva D; Eichhorst, Barbara; Stilgenbauer, Stephan; Jiang, Yanwen; Hallek, Michael; Fischer, Kirsten
